← Leaderboards
Paul Zolkind
St. Louis Va Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2024–25$1$1$1$0$0
'24
'25
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Early Phase Clinical Trial”
- Alpha Albert Lee · Sloan-Kettering Inst Can Research$33,555,942
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Peter Sjã · Sloan-Kettering Inst Can Research$22,733,967
- Suma Babu · Massachusetts General Hospital$20,303,231
- Sabrina Paganoni · Massachusetts General Hospital$20,303,231
- Michael George Natchus · Emory University$10,548,554
Research focus
Early Phase Clinical TrialAntioxidantsAnalogAdvanced DiseaseBiologicalBiologyCancer CellCancer ModelCancer PatientCarcinogensCell GrowthCell InjuryCell ProliferationCellsCheckpoint TherapyChemotherapyClinical PhenotypeCytoprotectionCytotoxicDhfr GeneDiagnosisDihydrofolate Reductase InhibitorDrug TargetingEfficacy Evaluation